Iterum Therapeutics plc (ITRMF) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2024 | $44.59M | +69.8% |
| 2023 | $26.26M | -60.7% |
| 2022 | $66.83M | -27.0% |
| 2021 | $91.51M | +179.1% |
| 2020 | $32.79M | +27.3% |
| 2019 | $25.75M | -73.7% |
| 2018 | $97.87M | +109.3% |
| 2017 | $46.76M | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2024 | $44.59M | +69.8% |
| 2023 | $26.26M | -60.7% |
| 2022 | $66.83M | -27.0% |
| 2021 | $91.51M | +179.1% |
| 2020 | $32.79M | +27.3% |
| 2019 | $25.75M | -73.7% |
| 2018 | $97.87M | +109.3% |
| 2017 | $46.76M | — |